Colonics
About Me
Recent Posts
- Researchers explore issues related to multiple myeloma treatment
- Electromagnetic Biomarker Could Minimize Trial-And-Error Prescribing For Depression
- Endocrine Society Releases Clinical Practice Guideline On Pediatric Obesity
- Key Role In Largest US Children's Study To Be Played By UT Health Science Center At Houston
- Scientists identify a molecule that coordinates the movement of cells
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
Friends
Links
Entry 1 of 390
Last Page | Next Page
7/2/2008
-
Brazilian organization files opposition to Gilead's antiretroviral patent application in India
|
The Brazilian group Interdisciplinary AIDS Association, or ABIA, has joined Indian patient advocacy groups to oppose a patent form for Gilead Science's antiretroviral drug Tenofovir, saying that the patent would have a direct impact on Brazil's ability to produce and access affordable generic versions of the drug, India's mtier test reports. Opponents of the patent say that the drug consists of a until now known jumble and, therefore, cannot be patented under India's Patents Act. More: - Read More
Technorati Tags: india, patent, that the, the drug, the patent
Filed under: india, patent, that the, the drug, the patent |
Post A Comment! :: Send to a Friend! |
Share and enjoy
